在儿科神经瘤学中免疫治疗临床试验的翻译性考虑
Jessica B Foster1, Marta M Alonso2, Elias Sayour3
1Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA USA.
Neoplasia (New York, N.Y.)
|May 27, 2023
概括
免疫疗法为儿童中枢神经系统 (CNS) 瘤提供了新的希望,这是儿童癌症治疗的罕见成功. 本综述探讨了当前和未来的临床试验,解决了中枢神经系统瘤中免疫瘤学的挑战和组合策略.
科学领域:
- 儿科神经瘤学 儿科神经瘤学
- 癌症免疫疗法癌症免疫疗法
- 中枢神经系统 (CNS) 瘤 中枢神经系统 (CNS) 瘤
背景情况:
- 免疫疗法在儿科癌症治疗方面取得了先进的进展,但对儿科中枢神经系统瘤的影响仍然有限.
- 在了解中枢神经系统瘤生物学方面的近期进展推动了新型免疫疗法的开发.
- 新兴的成功包括型病毒,疫苗,采用细胞疗法和免疫检查点抑制剂.
研究的目的:
- 审查儿童中枢神经系统瘤免疫治疗临床试验的当前和未来情况.
- 专注于临床试验开发,并应对该领域的独特挑战.
- 讨论儿科免疫瘤学的组合策略和未来方向.
主要方法:
- 对儿童中枢神经系统瘤近期治疗试验的综述.
- 分析免疫治疗临床试验开发中的挑战,包括毒性,疾病评估和相关研究.
- 讨论组合策略和未来的研究方向.
主要成果:
- 在针对儿科中枢神经系统瘤的免疫疗法开发方面取得了重大进展.
- 关键的挑战包括管理毒性,准确的疾病评估和进行相关研究.
- 合作努力对于推进该领域至关重要.
结论:
- 免疫疗法在治疗儿科中枢神经系统瘤方面具有显著的前景.
- 解决特定的临床试验挑战对于成功的翻译至关重要.
- 国际合作和创新策略将推动儿科免疫瘤学的未来进展.
更多相关视频
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.5K
相关概念视频
01:27Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
01:29Microorganisms in Medicine and Therapeutics
74
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
74
01:11Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K